Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of ...
For example, activated T helper type 1 lymphocytes secrete interferon (IFN)-γ, which has potent effects on osteoclastogenesis in vivo and in vitro. IFN-γ, however, is known to cause both bone ...
Clinical improvement was associated with reduced leukocyte infiltration and interferon-γ production, which predicted a sustained response to apheresis. The authors speculate that apheresis could ...